Uterine leiomyosarcoma is the most common type of uterine sarcoma. It is an extremely
aggressive malignancy associated with a poor overall prognosis. Women affected may vary …

To determine the location patterns of distant metastases at initial staging and outcomes of
ovarian, uterine, and cervical cancer patients. Data were obtained from the SEER database …

Leiomyosarcoma (LMS), a smooth muscle connective tissue tumor, is a rare form of cancer
which accounts for 5–10% of soft tissue sarcomas. This type of cancer is highly …

Uterine leiomyosarcoma (ULMS) is a malignant stromal tumor arising from the myometrium
with a poor prognosis and very limited response to current chemotherapy. This study aimed …

Background The conversion of the epithelial phenotype of cancer cells into cells with a
mesenchymal phenotype-so-called epithelial–mesenchymal transition (EMT)-has been …

Objectives To analyze the impact of perioperative characteristics on the risk of recurrence in
patients with uterine leiomyosarcomas. Methods A sub‐analysis of the SARComa of the …

Background Patients with recurrent/metastatic uterine leiomyosarcoma (U-LMS) have a
dismal prognosis. This phase II study aims to evaluate trabectedin efficacy and safety in …

Introduction: The recent emergence of immune checkpoint blockade therapy and the
progression of immunobiology in cancer have spurred an increasing interest in the …

Background Leiomyosarcoma is a highly malignant soft-tissue sarcoma with a poor
prognosis. In recent years, treatment for leiomyosarcoma has not shown much progress …

Purpose To report systemic immunological enhancement following preoperative spinal
embolization and total en bloc spondylectomy (TES) using tumor-bearing frozen autograft in …